In the adjusted cause-specific-hazard regression for the GLP-1 RA vs DPP-4 inhibitor cohort, GLP-1 RAs were associated with a lower risk of suicide or suicide attempts compared with DPP-4 inhibitors after 1 year follow-up (HR 365 0.58 [0.37;0.91])
Compound GLP-1s should be Used Carefully in Older Individuals and those with a History of Gastrointestinal Disease
Older adults lose muscle more quickly during weight loss
Certain medications may interact with retatrutide, potentially altering your bodys management of side effects
Quick Answer: Tirzepatide, a dual GIP/GLP-1 receptor agonist, appears to reduce persistent food-related thoughts ("food noise") through appetite regulation mechanisms, though individual responses vary considerably
The bridge program covers three FDA-approved GLP-1 medications when used for chronic weight management: Wegovy (semaglutide injection and tablets), Zepbound (tirzepatide KwikPen), and Foundayo (orforglipron, the first oral GLP-1 pill for weight loss)